For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

FP19

KSOSID1351

Dr.NEENA R
Membership No Author Name Email Mobile
KSOSID1351 Dr.NEENA R [email protected] 9562056099
Miscellaneous

EFFICACY&SAFETY OF ORAL METFORMIN IN DECELERATING PROGRESSION OF PEDIATRIC STARGARDT DISEASE(STGD-1)

To evaluate the efficacy and safety of oral Metformin in slowing progression of ABCA4 mutation positive Stargardt disease (STGD-1) in pediatric patients. STGD-1; the most common irremediable childhood recessively inherited macular dystrophy results in progressive vision loss. Metformin enhances cellular lipid metabolism by activating AMPK pathway & has anti-oxidative effects. This study analyses Metformin’s efficacy and favorable safety profile across pediatric STGD-1.

Membership No Author Name Email Mobile
KSOSID1925 Dr.Lekha T [email protected] 9842249987
KSOSID2441 Dr.Shivankar Sen [email protected] 8630893268
Non Member Dr.Gayathri M Satheesh [email protected] 7356675902